Citation: Sm. Aronson, COST-EFFECTIVENESS AND QUALITY-OF-LIFE IN PSYCHOSIS - THE PHARMACOECONOMICS OF RISPERIDONE, Clinical therapeutics, 19(1), 1997, pp. 139-147
Citation: Hj. Palamarchuk et Sm. Aronson, SLIPPED CAPITAL FEMORAL EPIPHYSIS IN A 12-YEAR-OLD MALE, Journal of the American Podiatric Medical Association, 86(1), 1996, pp. 48-50
Citation: Sm. Aronson, SILENT TRAVELERS - GERMS, GENES, AND THE IMMIGRANT MENACE - KRAUT,AM, The Journal of nervous and mental disease, 184(7), 1996, pp. 446-447
Citation: Hj. Palamarchuk et Sm. Aronson, OSTEOCHONDROSIS OF THE TARSAL NAVICULAR IN A FEMALE HIGH-SCHOOL DISTANCE RUNNER, Journal of the American Podiatric Medical Association, 85(4), 1995, pp. 226-229
Citation: Am. Mellow et al., A PEPTIDE ENHANCEMENT STRATEGY IN ALZHEIMERS-DISEASE - PILOT-STUDY WITH TRH-PHYSOSTIGMINE INFUSIONS, Biological psychiatry, 34(4), 1993, pp. 271-273
Authors:
MELLOW AM
FOSTER NL
ARONSON SM
GIORDANI B
STLAURENT RT
BERENT S
Citation: Am. Mellow et al., BEHAVIORAL-EFFECTS OF THE NMDA ANTAGONIST, KETAMINE, IN ALZHEIMERS-DISEASE, Biological psychiatry, 33(6A), 1993, pp. 142-142